Male patients (n = 38) with a diagnosis of schizophrenia, without substance abuse, and in contact with their families, were recruited at the time of hospital discharge. Patients' psychotic symptom levels were monitored every 2 weeks until follow-up, while family measures were administered at T1 and T2. The 4 predictor variables in the regression analysis were T1 symptom levels of the patient and 3 measures of family interaction (expressed emotion, family burden, and family functioning).
xpressed emotion research has found a relation between parental EE and early relapse for patients without determining whether this association is a function of the vulnerability of the patient, the emotional attitudes of the relative, or the interaction between them.
The relation between EE and relapse was first demonstrated for patients with schizophrenia and then affective disorders. [32] [33] [34] [35] [36] [37] [38] The link between EE and relapse has since been replicated across several diagnostic categories [39] [40] [41] and many cultural groups. [42] [43] [44] [45] [46] [47] [48] [49] [50] The relapse rate for patients from high EE families has been reported as 3 to 4 times higher than for patients from low EE families. 14, 15, 26, 27 Some EE research suggests a causal relation between relatives' characteristics and early relapse for patients. [24] [25] [26] [27] In commenting on the early EE literature, Vaughn 51 stated: "the differences (between high and low EE families) lie not in the patients but in the relatives-low EE and high EE relatives differ markedly in their response to patients' objective condition." p 99 However, King 52 and King et al 53 as well as others 32, [54] [55] [56] have questioned this direction of effects. Their findings suggest that EE status of relatives may be a response to symptom severity, rather than a cause of it.
In another line of investigation, EE research has examined a more interactive 8, [57] [58] [59] [60] model in which EE has been found to index both relatives' and patients' behaviours. Observed transactional studies of EE have demonstrated a reciprocal pattern of escalation between patient and parent that is associated with EE status.
It is this interactive hypothesis that our study seeks to address. Building on previous interactive and observed transactional research, we set out to examine the comparative influence of patients' and relatives' characteristics on symptomatic outcome in schizophrenia. In our study, we compare 3 models in the prediction of symptomatic outcome: a model based on patients' characteristics, a model based on relatives' characteristics, and a combined model based on both relatives' and patients' characteristics. It was hypothesized that, at followup, a combination of T1 patients' and relatives' characteristics, would give a better prediction of psychotic symptom severity at T2 than either patients' T1 or relatives' T1 characteristics alone.
Method
Ethics approval for this study was obtained from the University of Toronto and from each of the ethics boards of the participating hospitals.
The method was that of a 9-month, prospective longitudinal study of single male patients (n = 38) with schizophrenia and their families. These patients and families were first assessed 1-month postdischarge from hospital (T1) and then subsequently every 2 weeks throughout the follow-up study period until T2.
Sample Selection
With 4 predictor variables, we aimed for a convenience sample of subjects (n = 40) (10´the number of predictors). 61 However, 2 subjects dropped out of the study, hence our sample size was 38. The original subjects (n = 40) were selected from a subject pool of male patients (n = 328) referred from the inpatient psychiatric units of 12 hospitals in downtown Toronto and surrounding suburban and outlying areas. Patients were screened on the basis of a diagnosis of schizophrenia or schizoaffective psychosis (mainly schizophrenia) as detailed below. Among patients who met diagnostic criteria, exclusion from the sample was due to the following factors: refusal by either patients or relatives (25%); recent drug or alcohol abuse that might confound the diagnosis (18%); other comorbid diagnoses (11%); or insufficient contact with relatives (27%), defined as less than 10 hours per week, although the mean number of hours was 28 hours per week. For purposes of sample homogeneity, only single male patients were included, because of known male-female differences in prognosis.
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Diagnostic Criteria
Diagnosis was based on either a DSM diagnosis of schizophrenia, or Research Diagnostic Criteria, for schizoaffective psychosis, mainly schizophrenia, using the Schedule of Affective Disorders and Schizophrenia (Lifetime version).
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Procedure
A referral network for subject recruitment was established in the inpatient psychiatric units of 12 hospitals in downtown Toronto and suburban areas. Informed consent was obtained from patients and both parents in a 2-parent family, or 1 parent in a single-parent family.
Patients were assessed diagnostically for inclusion criteria on the basis of in-hospital interviews with the patient, with ward staff, by chart review, and by telephone contact with relatives. Patients were also assessed symptomatically, at discharge and then every 2 weeks, in person or by telephone, to determine psychotic symptom levels, using the Expanded BPRS. 64, 65 If a subject rated in the relapse range on the basis of a telephone interview, a subsequent face-to-face interview was arranged within 2 days to repeat the rating.
Measures
Relatives Characteristics
Family measures administered at T1 and T2 are described below and include EE, FB, and FF.
For the purpose of our study, family was defined as the patient and both parents in a 2-parent family, or as the patient and 1 parent in a single-parent family. Siblings were excluded because of the variability in the number of siblings among families and because few siblings still lived at home or maintained high contact with the patient.
Expressed Emotion. EE was rated from audiotapes of the Rochester Modified Format of the Camberwell Family Interview 6 by an expert rater. The cut-off for high EE was a score of more than 6 for Critical Comments and of more than 3 for Emotional Over-Involvement as specified for use with this instrument.
Family Burden. FB is a construct that serves as an index of aspects of family interaction that are specific to schizophrenia. The PFBS was developed at the Centre for Addiction and Mental Health, Clarke site. The PFBS is a self-report measure, rated by the relative, of the presence of 24 behaviours associated with schizophrenia and includes 2 subscores: 1. "Is this behaviour present?"
2. "How much does this behaviour bother you?" as rated on a 4-point Likert scale.
Reports of test development procedures and test validation data for the PFBS have been published. 66 Family Functioning. FF is a measure of normal family interaction operationalized by a self-report scale, Family Assessment Measure III.
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Patient Characteristics
Two T1 patient characteristics were included as predictor variables in the regression analysis, based on data from the correlational analysis described below. One such T1 patient variable was T1 symptom severity, using the BPRS. 64, 65 The second T1 patient characteristic measured was the number of patient problem behaviours demonstrated by the patient, as endorsed by the relative. This subscale is 1 of 2 subscales of the PFBS.
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Outcome
The outcome variable, symptomatic status at T2, was based on the level of psychotic symptoms on a symptom severity scale at relapse or 9 months postdischarge, whichever came first. Among the subjects in the sample (n = 38) during the 9-month study period, 17 relapsed, while 21 did not. Here, psychotic relapse was measured by the items, hallucinations, unusual thought content, or conceptual disorganization on the BPRS. 65, 66 Relapse was defined as Type I relapse specified by Falloon et al 73 and Falloon.
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Statistical Analyses
Partial correlations were used to examine the independent correlation of each T1 predictor variable with the T2 outcome variable, controlling for the contributions of other variables in the equation. The results of this correlational analysis suggested that patients' level of psychotic symptoms and FB at T1 were each most significantly correlated with T2 psychotic symptoms.
For this analysis, we then tested a regression model using the 3 specified variables. We did a multiple regression analysis of T1 patients' level of psychotic symptoms and T1 relatives' FB scores as predictors of patient psychotic symptom levels at T2.
Results
Description of the Sample
The sample of subjects (n = 38) was comprised of single, English-speaking men diagnosed with schizophrenia, with a mean age of 26.2 years, SD 5.62. Based on information from hospital and outpatient charts as well as patient and relative self-report, patients had not abused drugs or alcohol within the 3 months prior to the index admission. All outpatient psychiatrists judged patients in the sample to be adequately medicated throughout the study period based on good medication adherence and adequate dosage. During the 9-month study period, using the Falloon and colleagues relapse criteria, 73, 74 among the patients in our sample, 17 were judged to have relapsed, while 21 did not relapse. While our relapse rate was high (45%), compared with the about 39% reported as a current 1-year relapse rate in studies of early psychosis, 76 the patients in our sample were men and suffered from recurrent hospitalizations, despite adequate medication. This important difference in sample composition probably accounts for differences in relapse rates.
Social Functioning
Specific dimensions of subjects' social functioning such as level of education, interpersonal relationships, functional status, and living arrangements are described in Table 1 .
Outcome
In examining the influence of FB at T1 on T2 symptomatic outcome, we wondered whether FB changed with symptoms and therefore may simply reflect prodromal symptomatic changes in the patient. If this were the case, then FB may predict T2 symptomatic status through its association with symptoms. As expected, FB scores were found to increase between T1 and T2 for all families (F = 14.570, df = 1,36; P < 0.001); however, the scores increased significantly more for the families of patients who relapsed, (F = 8.76, df = 1,36; P < 0.005) than for patients who did not relapse, suggesting that FB may correspond to changes in patients' symptoms.
From the partial correlations, which included the total PFBS scores and the PFBS subscale scores described above, we found that the objective subscale (the presence of problem behaviours) did not significantly correlate with patients' symptoms at T2. Thus there was no support for the hypothesis that FB may simply correspond to illness behaviours associated with symptom severity. Rather, the extent to which the problem behaviour bothers the relative (the subjective component of FB) was independent of the level of patient symptoms. In other words, relatives may be highly bothered by behaviours that they rated as mild, or, alternatively, they may be bothered very little by behaviours they rated as extreme.
Results of the regression analysis, based on the model using the T1 psychotic symptom levels and the T1 PFBS scores as independent variables, were found to predict the dependent variable, level of T2 psychotic symptoms (F = 5.18, df = 2,35; P = 0.01). The combined portion of outcome variance explained by the predictor variables (based on an adjusted R 2 ) was 19% (10% by T1 symptoms and 9% by the subjective FB subscale). Neither T1 EE nor FF, nor the T1 objective subscale of FB, added to the prediction of psychotic symptoms levels at T2. For FF, while high EE families had significantly higher, more problematic scores on the self-report scale, Family Assessment Measure III, and its subsets than did low EE families, all scores fell within the normal range of FF at both time points.
Discussion
The main findings of our study are that a combination of patients' and relatives' characteristics account for the predicted variance (19%) in the level of psychotic symptoms at follow-up. The regression model that gave the best fit is the model comprised of 2 variables, the patient's remitted level of symptoms at T1 (10%) and the PFBS score at T1 (9%). Their contribution was found to be independent and additive. Moreover, examining the subtest scores, the subjective component of FB, the extent to which the behaviour bothered the relative, was the most salient aspect in the measurement of FB.
Our study suggests that symptomatic relapse for the patient may be a function of the interactions between patient and relative. Thus specific reactivity and perceived burden of relatives in response to symptoms and illness behaviour of the patient may synergistically interact to potentiate psychotic symptoms for the patient. The reason that T1 FB may be a better predictor of T2 symptoms than T1 EE may lie in the nature of the constructs that underlie these 2 instruments. EE is a measure of relatives' attitudes toward both illness and nonillness characteristics of the patient, whereas FB measures relatives' attitudes toward patient behaviours that are specific to schizophrenia, and therefore may be more directly related to symptomatic outcome.
The results of our study also suggest that, consistent with the findings of the Nithsdale study by McCreadie et al, 55 but not with the findings of King and Dixon, 76 remitted EE did not predict symptomatic outcome.
Limitations
Because the methodology and procedure of our study are unique relative to previous studies, results may not be comparable to previous research that predicts relapse from an acute measure of EE. Second, the only patient characteristics measured were the level of T1 psychotic symptoms and the T1 behaviours associated with illness symptoms. Other patient characteristics may add to the variance predicted in symptomatic outcome. Méthodes : Des patients masculins (n = 38) ayant reçu un diagnostic de schizophrénie, sans abus de substances, et en contact avec leurs familles ont été recrutés au moment de leur congé de l'hôpital. Les niveaux des symptômes psychotiques des patients étaient contrôlés à toutes les 2 semaines jusqu'au suivi, tandis que les mesures familiales étaient administrées à T1 et T2. Les 4 variables prédictrices de l'analyse de régression étaient les niveaux de symptômes du patient à T1 et 3 mesures de l'interaction de la famille (émotion exprimée, charge familiale, et fonctionnement familial).
Résultats : Le modèle basé sur la variable familiale, soit charge familiale à T1, et sur la variable du patient, soit les niveaux atténués des symptômes psychotiques des patients à T1, s'est révélé prédire significativement le niveau des symptômes psychotiques à T2. Ces 2 variables T1 contribuaient de façon indépendante et additive au niveau des symptômes psychotiques à T2, prédisant 19 % de la variance. Ni émotion exprimée ni fonctionnement familial à T1 n'ajoutaient à la prédiction.
Conclusion :
Ce résultat suggère une composante interactionnelle patient-famille d'une rechute symptomatique dans la schizophrénie.
